U.s. patent and trademark office rejects axonics' challenge to medtronic patents

Dublin, sept. 13, 2021 /prnewswire/ -- medtronic plc (nyse:mdt), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (ip) for its sacral neuromodulation device family, the interstim™ systems.
AXNX Ratings Summary
AXNX Quant Ranking